Neuropsychiatry PCD Franchise: A Profitable Pharma Opportunity
Discover Neuracle Lifesciences, a leading Neuropsychiatry PCD Franchise in India, dedicated to mental wellness with 300+ WHO-GMP, ISO, DCGI-approved products for schizophrenia, depression, bipolar, OCD, anxiety, and more—including anti-depressants, anti-psychotics, anxiolytics. Franchise perks: monopoly rights, incentives, promotional tools (MR bags, visual aids), on-time delivery, 20-50% margins. Tap into a market growing from USD 7.25B (2024) to 23.75B (2035) via eco-friendly, R&D-driven solutions for profitable, ethical growth.